.show-script { display: block; } .hide-script { display: none; }

Enable Javascript to enjoy full feature!

Dec 15, 2025

Radiopharm Theranostics (RADX) Stock Explode 200% After Brain Cancer Trial Breakthrough

Analysis Stocks

RADX stock: Radiopharm Theranostics shares jump 200% on positive Phase 2b brain metastases trial data showing 92% concordance with MRI imaging.

The post Radiopharm Theranostics (RADX) Stock Explode 200% After Brain Cancer Trial Breakthrough appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA $ARB $BITF $BLSH $BMNR $BONK $CLAW Token Scam $DBKSF $ENA $LUXFF $MATH $MTT token $NIGHT $PUMP $RAY $S $SEA $SOL $SPACE token $SPTZ